NASDAQ : PROF
Profound Medical Corp. — Key statistics
Healthcare · Medical Devices · Canada
Last price 5.86 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 214.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 240.36M |
| Enterprise Value | 208.92M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 36.53M |
| Shares Outstanding | 36.53M |
| Shares Change (YoY) | +20.87% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 2.82% |
| Owned by Institutions (%) | 50.57% |
| Float | 35.50M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.59 |
| Forward PS | 6.16 |
| PB Ratio | 4.83 |
| P/TBV Ratio | 4.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 10.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 6.46 |
| Quick Ratio | 5.25 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -73.53% |
| Return on Assets (ROA) | -39.46% |
| Return on Invested Capital (ROIC) | -43.66% |
| Return on Capital Employed (ROCE) | -66.39% |
| Weighted Average Cost of Capital (WACC) | 7.08% |
| Revenue Per Employee | $117,815 |
| Profits Per Employee | -$202,123 |
| Employee Count | 162 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 0.57 |
Taxes
| Measure | Value |
|---|
| Income Tax | 227,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.56 |
| 52-Week Price Change | +7.18% |
| 50-Day Moving Average | 6.23 |
| 200-Day Moving Average | 6.67 |
| Relative Strength Index (RSI) | 58.72 |
| Average Volume (20 Days) | 350,314 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.56M |
| Short Previous Month | 1.48M |
| Short % of Shares Out | 4.26% |
| Short % of Float | 4.39% |
| Short Ratio (days to cover) | 5.16 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 19.09M |
| Gross Profit | 13.70M |
| Operating Income | -35.37M |
| Pretax Income | -32.52M |
| Net Income | -32.74M |
| EBITDA | -34.88M |
| EBIT | -35.37M |
| Loss Per Share | -$1.00 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 38.27M |
| Total Debt | 7.38M |
| Net Cash | 30.89M |
| Net Cash Per Share | $0.85 |
| Equity (Book Value) | 49.81M |
| Book Value Per Share | 1.36 |
| Working Capital | 49.75M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -36.10M |
| Capital Expenditures | -176,000 |
| Depreciation & Amortization | 491,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -36.28M |
| FCF Per Share | -$0.99 |
Margins
| Measure | Value |
|---|
| Gross Margin | 71.79% |
| Operating Margin | -185.31% |
| Pretax Margin | -170.37% |
| Profit Margin | -171.56% |
| EBITDA Margin | -182.74% |
| EBIT Margin | -185.31% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -20.87% |
| Shareholder Yield | -20.87% |
| Earnings Yield | -15.18% |
| FCF Yield | -15.09% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $11.14 |
| Price Target Difference | 69.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 57.61% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 16, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.63 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |